Investment Summary

EQT Invests In SHL Medical

On January 3, 2020, private equity firm EQT invested in life science company SHL Medical

Investment Highlights
  • This is EQT’s 7th transaction in the Life Science sector.
  • This is EQT’s 8th transaction in Switzerland.

Investment Summary
Date 2020-01-03
Target SHL Medical
Sector Life Science
Investor(s) EQT
Deal Type Stake Purchase

Target

SHL Medical

Zug, Switzerland
SHL Medical is a developer and manufacturer of advanced drug delivery systems such as autoinjectors and partners to global pharma and biotech firms. SHL Medical was founded in 1989 and is based in Zug, Switzerland.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

EQT

Stockholm, Sweden

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1994
PE ASSETS 242.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

EQT is a global private equity group that purses a variety of investment strategies around the world. EQT is divided into several investment disciplines, including private capital, real assets, credit, and venture. The Firm's private capital group targets large, market-leading enterprises (investment size of €125 to €1.5 billion) across Europe and the US, as well as mid-market, growth companies (investment size of €40 to €125 million) across the US, Europe, China, and Southeast Asia. The Firm's real assets group seeks to identify control or co-control equity investments (investment size of €500 to €1 billion) in medium-sized infrastructure companies that provide an essential service to society, are recession resilient, and have secure cash flows. EQT's credit group provides flexible, long-term debt capital solutions to medium-sized European businesses, across a wide range of sectors. EQT was established in 1994 and is headquartered in Stockholm, Sweden.

DEAL STATS #
Overall 223 of 317
Sector (Life Science) 7 of 14
Type (Stake Purchase) 18 of 25
Country (Switzerland) 8 of 9
Year (2020) 1 of 19
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-20 Clinical Innovations

Murray, Utah, United States

Clinical Innovations is a developer, manufacturer, and marketer of medical devices that improve healthcare outcomes for clinicians and their patients. With particular emphasis on healthcare solutions for women and their infants, Clinical Innovations employs high-quality standards in every aspect of the business to make advancements in technology and bring innovative ideas to life. Clinical Innovations is based in Murray, Utah.

Sell $525M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-07 HMI Group

Singapore, Singapore

HMI Group is a growing regional private healthcare provider with a presence in Singapore, Malaysia, and Indonesia. HMI owns two tertiary hospitals in Malaysia, as well as a one-stop ambulatory care center, healthcare training center, and a stake in a General Practice clinic chain in Singapore. HMI Group was founded in 1998 and is based in Singapore.

Buy -
Mergr

Product

Company

Legal